We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-0.74%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$329M
AUM Growth
-$5.18M
Cap. Flow
-$1.43M
Cap. Flow %
-0.44%
Top 10 Hldgs %
34.34%
Holding
206
New
10
Increased
48
Reduced
89
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 20.89%
2 Technology 16.24%
3 Financials 10.88%
4 Industrials 9.41%
5 Communication Services 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
51
Intuit
INTU
$86.2B
$1.87M 0.57%
3,467
-60
-2% -$32.3K
ORCL icon
52
Oracle
ORCL
$369B
$1.86M 0.57%
21,395
-852
-4% -$75.3K
BIIB icon
53
Biogen
BIIB
$30.3B
$1.7M 0.52%
6,019
-20
-0.3% -$6.55K
VBR icon
54
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$1.7M 0.52%
10,060
-3,844
-28% -$658K
KO icon
55
Coca-Cola
KO
$377B
$1.63M 0.5%
31,079
-285
-0.9% -$15.9K
VMBS icon
56
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$1.54M 0.47%
28,880
-775
-3% -$41.4K
ETR icon
57
Entergy
ETR
$50.7B
$1.5M 0.46%
30,226
-620
-2% -$33.2K
CME icon
58
CME Group
CME
$96.6B
$1.46M 0.44%
7,552
+7
+0.1% +$1.42K
MOAT icon
59
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$1.46M 0.44%
19,938
+827
+4% +$62.3K
GIS icon
60
General Mills
GIS
$19.3B
$1.4M 0.43%
23,444
-627
-3% -$37.1K
BKNG icon
61
Booking.com
BKNG
$150B
$1.4M 0.43%
14,750
-1,075
-7% -$96.4K
NVS icon
62
Novartis
NVS
$298B
$1.38M 0.42%
16,903
+50
+0.3% +$4.5K
LHX icon
63
L3Harris
LHX
$51.6B
$1.32M 0.4%
5,996
CERN
64
DELISTED
Cerner Corp
CERN
$1.29M 0.39%
18,301
+1,988
+12% +$154K
VEU icon
65
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$1.24M 0.38%
20,301
-2,371
-10% -$149K
MDT icon
66
Medtronic
MDT
$109B
$1.22M 0.37%
9,734
+400
+4% +$51.8K
MDY icon
67
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$1.2M 0.37%
2,504
+1,288
+106% +$633K
LMT icon
68
Lockheed Martin
LMT
$134B
$1.19M 0.36%
3,441
+284
+9% +$103K
FDX icon
69
FedEx
FDX
$73.3B
$1.19M 0.36%
5,408
-160
-3% -$43.4K
ZBH icon
70
Zimmer Biomet
ZBH
$18B
$1.17M 0.35%
8,205
CET
71
Central Securities Corp
CET
$1.56B
$1.15M 0.35%
27,098
STT icon
72
State Street
STT
$50.7B
$1.13M 0.34%
13,372
-1,119
-8% -$97.3K
CARR icon
73
Carrier Global
CARR
$51.4B
$1.11M 0.34%
21,499
-190
-0.9% -$10.2K
NVDA icon
74
NVIDIA
NVDA
$4.75T
$1.11M 0.34%
53,480
+280
+0.5% +$5.81K
VTV icon
75
Vanguard Morningstar Value ETF
VTV
$188B
$1.1M 0.33%
8,132
+116
+1% +$16.2K

Similar funds

Roberts, Glore & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Roberts, Glore & Co held 206 positions worth $329M, down 1.5% from $334M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Roberts, Glore & Co's Q3 2021 filing shows 10 new, 48 increased, 89 reduced and 14 closed positions. Its largest new stake was Vertex Pharmaceuticals: 5,655 shares worth $1.03M. The largest sale was Baidu, an estimated $791K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q3 2021 buy was Vertex Pharmaceuticals: 5,655 shares worth $1.03M.
  • Roberts, Glore & Co added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2021, an estimated $633K increase.
  • Roberts, Glore & Co's biggest Q3 2021 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $658K.
  • Roberts, Glore & Co fully exited Baidu in Q3 2021, selling an estimated $791K.
  • Roberts, Glore & Co's ten largest holdings make up 34% of its $329M portfolio in Q3 2021.
  • Roberts, Glore & Co opened 10 new positions and closed 14 in Q3 2021.
  • Roberts, Glore & Co's portfolio value fell 1.5% quarter-over-quarter to $329M.

Based on Roberts, Glore & Co's 13F filing for Q3 2021, filed 12 Nov 2021.